Stockholders' Equity

3 Months Ended

Mar. 31, 2024

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Stockholders' Equity

(a) Treasury Stock. As of March 31, 2024, the Company had approximately $774.5 million remaining under its share repurchase authorization. The Company did not repurchase shares under the program during the three months ended March 31, 2024. The Company repurchased 0.1 million shares under the program for approximately $5.0 million during the three months ended March 31, 2023.

In addition, the Company acquired shares upon the vesting of certain restricted stock units ("RSUs") and performance restricted stock units ("PRSUs"), which were withheld to satisfy tax withholding obligations during each of the three months ended March 31, 2024 and 2023, respectively. The shares withheld were valued at the closing price of the stock on the New York Stock Exchange on the vesting date or first business day prior to vesting, resulting in $43.8 million and $30.7 million in treasury stock acquired during the three months ended March 31, 2024 and 2023, respectively.

(b) Accumulated Other Comprehensive Loss ("AOCL"). AOCL consisted of the following:

	Three Months Ended
	March 31,
(in millions)	2024		2023
Foreign Currency Translation
Balance at beginning of period	$	(135.5)	$	(175.3)
Other comprehensive loss:
Foreign currency translation adjustments (1)	(15.5)		14.9
Balance at end of period	$	(151.0)	$	(160.4)
Pensions
Balance at beginning of period	$	(1.2)	$	(1.6)
Other comprehensive loss:
Net change from period revaluations (2)	(0.3)		—
Balance at end of period	$	(1.5)	$	(1.6)

(1)	In 2024 and 2023, there were no tax impacts related to foreign currency translation adjustments and no amounts were reclassified to earnings.
(2)	In 2024, there were no tax impacts related to pension adjustments.